StreetInsider.com

Amgen (AMGN) Announces Launch of AMGEVITA (Biosimilar Adalimumab) Across Europe
StreetInsider.com
… severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-severe hidradenitis suppurativa; non-infectious intermediate, posterior and
Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across EuropeBioSpace (press release) (blog)
Amgevita, INN-adalimumab – European Medicines Agency – Europa EUEuropean Medicines Agency – Europa EU
Amgen Launches AMGEVITA™ (Biosimilar Adalimumab) In Markets Across EuropePR Newswire

all 24 news articles »

X